BESORFIB
The "BESORFIB" trademark, serial number 85207037 , was filed on 29th of December 2010 with a mark drawing code of 4000 and its transaction date is 85207037. The attorney assigned is Katrina Edge, attorney docket number BESORFIB / U. Since 17th of May 2012, the document can be found in the M70 law office in the publication and issue section. The employee responsible is GAAFAR, SAMIR MICHAEL and the date it was published for opposition on 03/22/2011. The date when we last checked the status of this trademark was 11/09/2011.
The "BESORFIB" trademark, serial number 86142823 , was filed on 13th of December 2013 with a mark drawing code of 4000 and its transaction date is 86142823. The attorney assigned is Seana Smith, attorney docket number BESORFIB / U. Since 11th of March 2014, the document can be found in the M70 law office in the publication and issue section. The status of this trademark was checked last on 03/11/2014.
The corresponded responsible for this trademark is SEANA SMITH, located at PFIZER INC., 235 E 42ND ST, NEW YORK, NY 10017-5703.The state or country where the trademark was organized is NY by Pfizer Inc.. The legal entity type behing it is a Corporation, located at 235 East 42nd Street, New York, NY zip 10017.Other trademarks by this applicant: ACITEK, NETCAP, TOLEJI.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 12/27/2013 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 03/11/2014 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | O - Outgoing Correspondence | GNS3 | |
| 03/11/2014 | LETTER OF SUSPENSION E-MAILED | F - First Action | GNSL - LETTER OF SUSPENSION E-MAILED | |
| 03/11/2014 | SUSPENSION LETTER WRITTEN | R - Renewal | CNSL - SUSPENSION LETTER WRITTEN | |
| 03/10/2014 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 12/27/2013 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 12/17/2013 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.